BRIEF published on 11/07/2024 at 22:10, 15 days 12 hours ago MicroVision Reports Q3 2024 Financial Results Financial Performance MicroVision Lidar Technology Q3 2024 Results Capital Commitment
PRESS RELEASE published on 11/07/2024 at 22:05, 15 days 12 hours ago MicroVision Announces Third Quarter 2024 Results MicroVision, Inc. announces Q3 2024 results. Active engagement with automotive OEMs and industrial companies. Sequential cash burn improvement and $75 million capital commitment for future opportunities MicroVision Automotive Q3 2024 Results Industrial Cash Burn
BRIEF published on 08/07/2024 at 22:06, 3 months 15 days ago MicroVision Announces Second Quarter 2024 Results Adjusted EBITDA Revenue Increase Net Loss Automotive OEMs Q2 2024 Results
PRESS RELEASE published on 08/07/2024 at 22:01, 3 months 15 days ago MicroVision Announces Second Quarter 2024 Results MicroVision, Inc. announces Q2 2024 results, highlighting revenue growth and engagement with global OEMs. Financials show increased revenue and strategic cost management Revenue Growth MicroVision Cost Management Q2 2024 Results Global OEMs
BRIEF published on 05/09/2024 at 22:10, 6 months 13 days ago MicroVision Announces First Quarter 2024 Results Automotive Industry MicroVision Lidar Technology Q1 2024 Financial Results Fiscal Management
PRESS RELEASE published on 05/09/2024 at 22:05, 6 months 13 days ago MicroVision Announces First Quarter 2024 Results MicroVision, Inc. announces first quarter 2024 results, including revenue of $1.0 million, and strategic focus on high-volume OEM engagements and revenue growth in industrial markets Revenue Growth First Quarter Results MicroVision Inc. OEM Engagements Industrial Markets
BRIEF published on 03/05/2024 at 14:35, 8 months 17 days ago MicroVision Introduces $150 Million ATM Equity Facility with Top Financial Institutions MicroVision Technology Investment ATM Equity Offering Lidar Technology Automotive OEMs
PRESS RELEASE published on 03/05/2024 at 14:30, 8 months 17 days ago MicroVision Announces $150 Million At-The-Market Equity Facility MicroVision, Inc. enters $150 million ATM equity offering sales agreement with sales agents Deutsche Bank Securities, Mizuho, and Craig-Hallum Capital Group to support operational growth Investment Sales Agreement MicroVision Equity Offering Automotive Lidar
PRESS RELEASE published on 12/04/2023 at 09:00, 11 months 19 days ago Luxoft and MicroVision Join Forces to Enhance ADAS Automated Testing at Scale Luxoft and MicroVision have collaborated to develop a new generation of testing and simulation environments for advanced driver assistance systems (ADAS) and autonomous drive (AD) applications Luxoft MicroVision Testing Simulation Environments ADAS
PRESS RELEASE published on 08/08/2023 at 22:01, 1 year 3 months ago MicroVision Announces Second Quarter 2023 Results
Published on 11/22/2024 at 23:55, 10 hours 38 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 3 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 11 hours 28 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 3 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 16 hours 18 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 16 hours 39 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 17 hours 37 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 18 hours 33 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 15 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 16 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
